Genetic divergence in the clonal evolution of breast cancer - PubMed (original) (raw)
. 1996 Apr 1;56(7):1493-7.
Affiliations
- PMID: 8603391
Genetic divergence in the clonal evolution of breast cancer
H Fujii et al. Cancer Res. 1996.
Abstract
The progression of ductal carcinoma in situ (DCIS) to infiltrating and metastatic cancer of the breast is thought to be a consequence of clonal expansions of neoplastic cells with progressively more genetic alterations. To study this progression, we first dissected multiple foci from each of 23 breast tumors with DCIS only and 20 cases with synchronous DCIS and infiltrating cancer. We than tested microsatellite markers by PCR for allelic losses in the individual foci for loci on chromosomes 6q, 9p, 11q, 13q, 16q, 17q, and 17p. The patterns of allelic losses identified in the in situ cancers were generally conserved in the synchronous infiltrating tumors, supporting the paradigm that the infiltrating tumors are clonally derived from the in situ lesions. However, in 8 (40%) of the 20 cases with synchronous in situ and invasive cancer, heterogeneous patterns of allelic loss at one or more chromosomal loci were observed in adjacent DCIS foci. Moreover, some of the allelic losses recognized in in situ portions of the tumors were not conserved in the clonal progression to the synchronous invasive tumor. Such allelic loss heterogeneity was noted in only 1 of the 20 infiltrating tumors and only 3 of the 23 cases of DCIS without invasion that were studied in a similar manner. This heterogeneity indicated genetic divergence during the clonal evolution of breast cancer, particularly at the time when in situ cancers progress to invasive cancers.
Similar articles
- Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E. Fujii H, et al. Cancer Res. 1996 Nov 15;56(22):5260-5. Cancer Res. 1996. PMID: 8912866 - Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H. Radford DM, et al. Cancer Res. 1995 Aug 1;55(15):3399-405. Cancer Res. 1995. PMID: 7614479 - Genetic pathways in the evolution of breast ductal carcinoma in situ.
Farabegoli F, Champeme MH, Bieche I, Santini D, Ceccarelli C, Derenzini M, Lidereau R. Farabegoli F, et al. J Pathol. 2002 Mar;196(3):280-6. doi: 10.1002/path.1048. J Pathol. 2002. PMID: 11857490 - Genome evolution in ductal carcinoma in situ: invasion of the clones.
Casasent AK, Edgerton M, Navin NE. Casasent AK, et al. J Pathol. 2017 Jan;241(2):208-218. doi: 10.1002/path.4840. Epub 2016 Nov 27. J Pathol. 2017. PMID: 27861897 Free PMC article. Review.
Cited by
- Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.
Bowes AL, Tarabichi M, Pillay N, Van Loo P. Bowes AL, et al. J Pathol. 2022 Jul;257(4):466-478. doi: 10.1002/path.5914. Epub 2022 May 23. J Pathol. 2022. PMID: 35438189 Free PMC article. Review. - Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.
Sinha VC, Piwnica-Worms H. Sinha VC, et al. J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):191-205. doi: 10.1007/s10911-018-9410-6. Epub 2018 Sep 7. J Mammary Gland Biol Neoplasia. 2018. PMID: 30194658 Free PMC article. Review. - Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.
Avril S. Avril S. Pathologe. 2017 Nov;38(Suppl 2):180-191. doi: 10.1007/s00292-017-0375-9. Pathologe. 2017. PMID: 29119232 Free PMC article. Review. - Intratumor and Intertumor Heterogeneity in Melanoma.
Grzywa TM, Paskal W, Włodarski PK. Grzywa TM, et al. Transl Oncol. 2017 Dec;10(6):956-975. doi: 10.1016/j.tranon.2017.09.007. Epub 2017 Oct 24. Transl Oncol. 2017. PMID: 29078205 Free PMC article. Review. - Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancer.
Dias MF, Blumenstein R, Russo J. Dias MF, et al. Oncol Lett. 2017 May;13(5):3831-3836. doi: 10.3892/ol.2017.5892. Epub 2017 Mar 22. Oncol Lett. 2017. PMID: 28521483 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical